Empirical Spine Submits PMA Module II for Limiflex™ as a New Motion-Preserving, Minimally Invasive Standard in Spine Surgery — Empirical Spine
San Carlos, Calif. (April 27, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, recently submitted Premarket Approval (PMA) Module II in the US Food & Drug Administration (FDA) […]





